Brain

From Geneva to Tokyo: World Meditation League Launches Quantified Meditation Challenge

GENEVA, Sept. 18, 2025 /PRNewswire/ -- Following the landmark Geneva Meditation Challenge in June, the World Meditation League (WML), in partnership with All…

5 months ago

Achieve Life Sciences Promotes Craig Donnelly to Chief Operations Officer

Donnelly brings more than 25 years of biopharmaceutical expertise in CMC and regulatory operationsSEATTLE and VANCOUVER, British Columbia, Sept. 18,…

5 months ago

Grace Therapeutics Granted Sixth U.S. Patent Covering I.V. Dosing Regimen for GTx-104

Grant of First Method of Use Patent Adds New Pillar to Grace’s Multi-layered Intellectual Property and Potential Market Exclusivity Protection…

5 months ago

Bio Protocol Raises $6.9M to Launch AI-Native Decentralized Science Platform for Biotech Funding & Drug Discovery

Bio Protocol enables researchers and patients to launch BioAgents - autonomous AI co-scientists that generate hypotheses, fund experiments and monetize biotech…

5 months ago

Linus Health’s AI-Driven Voice Analysis Technology Recognized in Gartner® Hype Cycle™ for Digital Care Delivery, 2025

BOSTON, Sept. 17, 2025 /PRNewswire/ -- Linus Health, an AI-driven brain health company pioneering early detection of cognitive impairment and…

5 months ago

ALLT.AI unveils the next generation of Large Language Models (LLMs) driven by the remarkable power and efficiency of the human brain

Translating decades of clinical neuroscience research into next-generation AI—ALLT.AI harnesses key data from damaged brains to create radically more efficient…

5 months ago

Aoki Games & Gala 2025 Returns to Las Vegas Sunday, September 21

Live performance, visionary conversations, and a tribute to Ray Kurzweil unite in support of brain health and innovation. LAS VEGAS,…

5 months ago

Apollo Biowellness, Inc., to Merge with Revive Regenerative, Inc.

North Bergen, New Jersey--(Newsfile Corp. - September 17, 2025) - Apollo Biowellness, Inc. (OTCID: KOAN) (the "Company") is pleased to…

5 months ago

NovalGen to Begin World’s First Clinical Trial for a Self-Regulating Immunotherapy

LONDON, Sept. 17, 2025 (GLOBE NEWSWIRE) -- The world’s first therapeutic drug to be equipped with NovalGen’s pioneering AutoRegulation (AR)…

5 months ago

Cingulate Secures Exclusive Manufacturing Partnership with Bend Bio Sciences to Support Future Commercialization of Next Generation ADHD Treatment

Strategic Commercial Supply Agreement Positions Lead Asset CTx-1301 for Launch Pending FDA ApprovalKANSAS CITY, Kan., Sept. 17, 2025 (GLOBE NEWSWIRE)…

5 months ago